Consumer access to clozapine in Australia: how does this compare to New Zealand and the United Kingdom?
Background: Clozapine is an antipsychotic medication used in treatment resistant schizophrenia. However, clozapine is associated with a significant adverse effect profile and extensive monitoring is required to optimise consumer safety. Traditionally, clozapine can only be prescribed by a psychiatri...
Saved in:
Main Authors: | Knowles SA (Author), McMillan SS (Author), Wheeler AJ (Author) |
---|---|
Format: | Book |
Published: |
Centro de Investigaciones y Publicaciones Farmaceuticas,
2016-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Implementing a clozapine supply service in Australian community pharmacies: barriers and facilitators
by: Bethany Wilson, et al.
Published: (2019) -
Regulatory responses to over‐the‐counter codeine analgesic misuse in Australia, New Zealand and the United Kingdom
by: Claire L. Tobin, et al.
Published: (2013) -
Rural chronic disease research patterns in the United Kingdom, United States, Canada, Australia and New Zealand: a systematic integrative review
by: R. Disler, et al.
Published: (2020) -
Cross-National Outcomes of a Digital Weight Loss Intervention in the United States, Canada, United Kingdom and Ireland, and Australia and New Zealand: A Retrospective Analysis
by: Qiuchen Yang, et al.
Published: (2021) -
Implementing chronic disease self management approaches in Australia and the United Kingdom
by: Colette Joy Browning, et al.
Published: (2015)